Pfizer
Amoy Diagnostics, Pierre Fabre Collaborate to Develop CDx in China
The companion diagnostic kits will support marketing authorization applications for Pfizer's Braftovi and Mektovi.
The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics.
Sema4 to Acquire GeneDx for $623M
While GeneDx parent Opko Health is essentially exiting the MDx business, it will pick up a "significant" stake in Sema4.
BD Partners With Pfizer, Wellcome to Study Role of Diagnostics in Antimicrobial Resistance
The partners will survey existing diagnostic practices to understand the benefits and gaps in diagnostic testing in antimicrobial resistance stewardship.
Exact Sciences, Pfizer End Cologuard Copromotion Agreement
In September, Exact hired 400 former Pfizer sales reps who were displaced from their jobs in late August and who had been promoting Cologuard.
Oct 30, 2020
Opko Health Q3 Revenues Up 87 Percent
Feb 24, 2020
Apr 30, 2019
Exact Sciences Q1 Revenues Up 79 Percent
Oct 30, 2018
Exact Sciences Q3 Revenues Up 63 Percent
Oct 12, 2018
AmoyDx Lung Cancer CDx Approved in South Korea
Aug 22, 2018